Hepatoblastoma Treatment: How It Works, Results and What to Expect

Hepatoblastoma treatment is planned by a specialist pediatric cancer team and most often combines chemotherapy with surgery to remove the tumor. The exact approach depends on whether the tumor can be removed safely, whether it has spread, and how it responds to initial treatment.

Hepatoblastoma Treatment: How It Works

Hepatoblastoma treatment aims to remove or destroy all cancer cells while preserving as much healthy liver function as possible. Hepatoblastoma is a rare liver cancer that occurs mainly in young children. Treatment is individualized, but it commonly includes chemotherapy, surgery, and careful follow-up after treatment has ended.

For many children, chemotherapy is given first. This can shrink the tumor, make an operation safer, and treat cancer cells that may be too small to see on scans. Afterward, a pediatric liver surgeon removes the part of the liver containing the tumor when this can be done completely and safely. The liver has a strong ability to regenerate, so children can often recover well after removal of part of the liver.

If the tumor involves major blood vessels or several areas of the liver and cannot be removed with a partial liver operation, a liver transplant may offer the best chance of complete treatment when the cancer has not spread beyond the liver. Decisions are made by a team that may include pediatric oncologists, liver surgeons, transplant specialists, radiologists, pathologists, anesthesiologists and supportive-care professionals.

Who May Need Each Type of Treatment

Every child with suspected or confirmed hepatoblastoma should be assessed at a center experienced in pediatric liver tumors. The treatment plan is based on the child’s age and general health, the size and location of the tumor, its relationship to major liver blood vessels, whether the tumor has spread, and laboratory findings such as alpha-fetoprotein (AFP) levels.

Doctors often use imaging-based staging systems to describe how much of the liver is affected before treatment. A tumor limited to one area of the liver may be removable at diagnosis. Larger tumors, tumors affecting multiple liver sections, or tumors close to important vessels are often treated with chemotherapy before surgery.

Children whose tumors remain limited to the liver but cannot be completely removed by partial hepatectomy may be evaluated for transplantation. Children with disease outside the liver may still receive intensive treatment, but the care team will assess response to chemotherapy and whether all known disease can be treated. The family is included in discussions about the expected goals, sequence and practical demands of care.

Assessment and Treatment Planning

Diagnosis and treatment planning usually begin with a detailed medical history, physical examination, blood tests and imaging. Ultrasound may identify a liver mass, while contrast-enhanced MRI or CT provides a detailed map of the tumor and nearby blood vessels. Imaging of the chest is also commonly performed because the lungs are a possible site of spread.

Blood tests assess liver function, kidney function, blood counts and AFP. AFP is often markedly elevated in hepatoblastoma and can be a useful marker for monitoring treatment response. However, results are interpreted together with scans and clinical findings, not in isolation.

A biopsy may be needed to confirm the diagnosis before chemotherapy, particularly when imaging and laboratory findings do not provide enough certainty. In some situations, the surgical team may decide that a tumor can be removed directly. Pathologists examine tumor tissue to confirm the diagnosis and provide information that helps guide ongoing care.

• Imaging helps determine whether surgery is possible and how much liver is involved.
• AFP trends can help monitor response and detect possible recurrence during follow-up.
• Multidisciplinary review helps coordinate cancer treatment, surgery, anesthesia, nutrition and family support.

Treatment Step by Step

The sequence of hepatoblastoma treatment depends on the tumor’s resectability, meaning whether it can be completely removed. When a tumor is removable at diagnosis, surgery may be performed first, followed by chemotherapy in selected cases. More commonly, chemotherapy is started before surgery to reduce the tumor size and improve the likelihood of complete removal.

Chemotherapy is delivered in planned cycles with rest periods between them. The medicines used are selected by the pediatric oncology team according to established treatment protocols and the child’s risk group. During treatment, regular blood tests, symptom checks and imaging help the team assess response and manage side effects.

After initial chemotherapy, the child has repeat scans to reassess surgery. A partial hepatectomy removes the tumor with a margin of healthy tissue when feasible. If complete removal is not possible because of the tumor’s position, the team may discuss liver transplantation as part of the treatment pathway. Additional chemotherapy may be recommended after surgery depending on the original extent of disease, surgical findings and response to treatment.

For families seeking coordinated care, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals provide assessment and treatment planning for international patients with complex pediatric liver tumors.

Surgery, Transplant and Recovery Timeline

Before liver surgery, the child undergoes anesthesia assessment and may need blood tests, imaging and preparation for hospital admission. During a partial liver resection, the surgeon removes the cancerous portion of the liver while protecting major vessels and bile ducts. The removed tissue is examined to confirm whether the tumor was fully excised.

After surgery, children are monitored closely for pain, bleeding, infection, liver function and return of normal eating and bowel activity. Some children spend time in a pediatric intensive care setting before moving to a regular ward. The length of hospital stay varies with the extent of surgery, the child’s recovery and whether complications occur.

Recovery continues at home with wound care, activity guidance, nutrition support and scheduled follow-up visits. Energy levels and appetite may return gradually, especially when chemotherapy is also being given. Children who receive a transplant need lifelong anti-rejection medicine, regular monitoring and infection-prevention guidance. Pediatric oncology care supports treatment planning and follow-up throughout this process.

Benefits, Risks and Supportive Care

The main benefit of combined therapy is that it can make complete tumor removal possible and reduce the risk that cancer cells remain after surgery. Outcomes vary considerably according to tumor extent, AFP level, response to chemotherapy, spread outside the liver and whether complete surgical removal is achieved. The child’s oncology team is best placed to discuss the outlook for an individual case.

Chemotherapy may cause temporary side effects such as nausea, vomiting, tiredness, reduced appetite, hair loss, mouth sores, lowered blood counts and greater susceptibility to infection. Some medicines can also affect hearing, kidneys, nerves or heart function, so clinicians monitor children carefully during and after treatment. Families should promptly report fever, unusual bleeding, breathing difficulty, dehydration, severe pain or a child who appears significantly unwell.

Surgical risks include bleeding, infection, bile leakage, blood clots, anesthesia-related complications and temporary changes in liver function. Transplantation has additional risks, including rejection, infection and medicine-related effects. Supportive care is an essential part of treatment and may include nutrition counseling, pain control, psychological support, physiotherapy, social work support and assistance with developmental needs.

When to Seek Medical Care and Follow-Up

A parent or caregiver should arrange prompt medical assessment if a child has a persistent or enlarging abdominal swelling, abdominal pain, poor appetite, unexplained weight loss, vomiting, tiredness, jaundice, or a noticeable lump in the abdomen. These symptoms can have many causes and do not necessarily indicate cancer, but they should be assessed by a qualified clinician.

During chemotherapy or after surgery, urgent medical advice is needed for fever, chills, difficulty breathing, uncontrolled vomiting, signs of dehydration, new yellowing of the eyes or skin, increasing abdominal swelling, unusual bruising or bleeding, or marked changes in alertness or behavior. Families should follow the emergency contact instructions provided by their child’s treating team.

Long-term follow-up generally includes physical examinations, AFP testing and imaging at intervals determined by the oncology team. These appointments help identify recurrence early and monitor potential late effects of cancer therapy. Survivorship care may also address vaccination, schooling, emotional wellbeing, growth and development.

Frequently asked questions

What is the main treatment for hepatoblastoma?

The main treatment is complete removal of the tumor by surgery when this is possible. Chemotherapy is commonly used before surgery to shrink the tumor and may also be used afterward, depending on the child’s individual treatment plan.

Can hepatoblastoma be treated without surgery?

Chemotherapy can shrink and control hepatoblastoma, but surgery or liver transplantation is usually needed to remove all disease when treatment is intended to be curative. The care team will determine whether partial liver surgery or transplantation is appropriate.

When is liver transplantation used for hepatoblastoma?

Liver transplantation may be considered when the tumor is confined to the liver but cannot be safely and completely removed by partial liver surgery. This can include tumors involving major blood vessels or multiple sections of the liver.

How long does hepatoblastoma treatment take?

Treatment duration varies according to the tumor stage, response to chemotherapy, type of operation and recovery needs. Families should expect treatment and follow-up to extend over months, with continued surveillance after active treatment ends.

What are the side effects of hepatoblastoma chemotherapy?

Possible side effects include tiredness, nausea, vomiting, reduced appetite, hair loss, mouth sores and low blood counts. Some chemotherapy medicines may affect organs such as the kidneys or hearing, which is why children have regular monitoring throughout treatment.

Can hepatoblastoma come back after treatment?

Recurrence is possible, which is why regular follow-up with examinations, AFP testing and imaging is important. The likelihood varies between children and depends on factors such as the original tumor extent, response to treatment and whether complete tumor removal was achieved.

References

• National Cancer Institute
• Children's Oncology Group
• American Cancer Society
• European Society for Paediatric Oncology
• World Health Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.